Compile Data Set for Download or QSAR
Report error Found 83 of ic50 data for polymerid = 50006410
LigandPNGBDBM694531(US20240294467, Compound 7A)
Affinity DataIC50: 11nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694592(US20240294467, Compound 21)
Affinity DataIC50: 24nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694530(US20240294467, Compound 5A)
Affinity DataIC50: 30nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694569(US20240294467, Compound 13)
Affinity DataIC50: 44nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694499(c(y-(NHex-Gua-But-Ac)a-R-Nal-G) | US20240294467, C...)
Affinity DataIC50: 48nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694535(US20240294467, Compound 51)
Affinity DataIC50: 52nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694542(US20240294467, Compound 4)
Affinity DataIC50: 54nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694545(US20240294467, Compound 5)
Affinity DataIC50: 55nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694538(US20240294467, Compound 52)
Affinity DataIC50: 55nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694589(US20240294467, Compound 20)
Affinity DataIC50: 63nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694601(US20240294467, Compound 24)
Affinity DataIC50: 66nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694604(US20240294467, Compound 25)
Affinity DataIC50: 68nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694563(US20240294467, Compound 11)
Affinity DataIC50: 80nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694578(US20240294467, Compound 41)
Affinity DataIC50: 90nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694560(US20240294467, Compound 10)
Affinity DataIC50: 91nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694572(US20240294467, Compound 14)
Affinity DataIC50: 120nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694557(US20240294467, Compound 9)
Affinity DataIC50: 150nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694536(US20240294467, Compound 2)
Affinity DataIC50: 180nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694571(US20240294467, Compound 63)
Affinity DataIC50: 220nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694587(US20240294467, Compound 44)
Affinity DataIC50: 240nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694598(US20240294467, Compound 23)
Affinity DataIC50: 240nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694539(US20240294467, Compound 30 | US20240294467, Compou...)
Affinity DataIC50: 280nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694539(US20240294467, Compound 30 | US20240294467, Compou...)
Affinity DataIC50: 280nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694596(US20240294467, Compound 47)
Affinity DataIC50: 320nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694541(US20240294467, Compound 53)
Affinity DataIC50: 360nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694529(US20240294467, Compound 2A)
Affinity DataIC50: 390nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694595(US20240294467, Compound 22)
Affinity DataIC50: 420nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694533(US20240294467, Compound 1)
Affinity DataIC50: 530nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694551(US20240294467, Compound 7)
Affinity DataIC50: 590nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694576(US20240294467, Compound 65)
Affinity DataIC50: 600nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694574(US20240294467, Compound 64)
Affinity DataIC50: 650nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694548(US20240294467, Compound 6)
Affinity DataIC50: 700nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694584(US20240294467, Compound 43)
Affinity DataIC50: 760nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694593(US20240294467, Compound 46)
Affinity DataIC50: 870nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694554(US20240294467, Compound 8)
Affinity DataIC50: 1.10E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694566(US20240294467, Compound 12)
Affinity DataIC50: 1.30E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694581(US20240294467, Compound 42)
Affinity DataIC50: 1.30E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694590(US20240294467, Compound 45)
Affinity DataIC50: 2.10E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694605(US20240294467, Compound 50)
Affinity DataIC50: 2.30E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM50447833(CHEMBL3114085)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of human recombinant N-terminal His6-Smt3-fusion-tagged Usp9x catalytic domain expressed in Escherichia coli using Ub-AMC as substrate inc...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM50437695(CHEMBL1923233)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of USP9x (unknown origin)More data for this Ligand-Target Pair
In DepthDetails
PubMed
LigandPNGBDBM50437695(CHEMBL1923233)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of USP9x in human Z138 cells after 1 hr by immunoblotting analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM694544(US20240294467, Compound 54)
Affinity DataIC50: 3.40E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694550(US20240294467, Compound 56)
Affinity DataIC50: 4.50E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694547(US20240294467, Compound 55)
Affinity DataIC50: 4.70E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694556(US20240294467, Compound 58)
Affinity DataIC50: 4.90E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694602(US20240294467, Compound 49)
Affinity DataIC50: 5.00E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM694565(US20240294467, Compound 61)
Affinity DataIC50: 5.80E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

LigandPNGBDBM50437695(CHEMBL1923233)
Affinity DataIC50: 5.90E+3nMAssay Description:Inhibition of human recombinant N-terminal His6-Smt3-fusion-tagged Usp9x catalytic domain expressed in Escherichia coli using Ub-AMC as substrate inc...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
LigandPNGBDBM694549(US20240294467, Compound 32 | US20240294467, Compou...)
Affinity DataIC50: 6.00E+3nMAssay Description:USP9X enzyme assays were set up in a 96 well plate to assess the abilities of Compound 3A and Compound 4A to inhibit the activity of USP9X, respectiv...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
US Patent

Displayed 1 to 50 (of 83 total ) | Next | Last >>
Jump to: